Form 4: LeMaitre Vascular CEO Reports Stock Transactions Following Vesting of Stock Units
SEC Form 4 Filing
LeMaitre Vascular's CEO, George W. LeMaitre, reported the acquisition of shares through the vesting of stock units and the subsequent withholding of shares to cover tax obligations.
Summary
- George W. LeMaitre, CEO of LeMaitre Vascular, reported several transactions involving the company's common stock.
- These transactions occurred on December 11th and 12th, 2024.
- The transactions include the acquisition of shares through the vesting of restricted stock units and performance stock units.
- A portion of the shares were withheld by the company to satisfy tax obligations.
- The CEO's total holdings decreased slightly from 1,893,650 to 1,891,739 shares due to the tax withholding.
- Dividend equivalent rights were also released in connection with the vesting of the stock units.
Sentiment
Score: 7
Explanation: The document reflects routine insider transactions related to stock-based compensation. There is no indication of positive or negative sentiment, it is a neutral event.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the stock ownership changes of key executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
- The transactions reported are typical for executives receiving stock-based compensation, such as restricted stock units and performance stock units.
- The tax withholding mechanism is a common practice to cover tax liabilities associated with vesting of stock awards.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine stock-based compensation and tax withholding.
- The transactions do not have a significant impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/11/2024 | Date of the earliest reported transaction, including the vesting of restricted stock units and release of dividend equivalent rights. |
| 12/12/2024 | Date of further transactions, including the vesting of additional restricted stock units and performance stock units, and release of dividend equivalent rights. |
| 12/13/2024 | Date the Form 4 was signed. |
Keywords
stock transactions, Form 4, insider trading, stock vesting, restricted stock units, performance stock units, dividend equivalent rights, tax withholding, LMAT, LeMaitre Vascular
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.